Preliminary data from Israel this week regarding Pfizer’s vaccine for the coronavirus is raising questions about how vaccines work over time against variants like delta. To break this down, host Marco Werman speaks with Dr. Anna Durbin, a professor of international health at Johns Hopkins Bloomberg School of Public Health. Durban explains why she still doesn’t find such results worrying.